ICOpre – the story behind a new, generic inhaler platform to Ellipta
Iconovo has developed a new and innovative dry powder inhaler platform – ICOpre – aimed for a global market. ICOpre is a pre-metered dry powder inhaler for simple, once-daily treatment, containing 30 individually sealed doses.
Hear dr Orest Lastow, founder and CTO at Iconovo, tell the story about the development process and business opportunities ICOpre enables.
